Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov;45(11):2553-2559.
doi: 10.1007/s11064-020-03111-1. Epub 2020 Aug 25.

Exosomes in Alzheimer's Disease: Potential Role as Pathological Mediators, Biomarkers and Therapeutic Targets

Affiliations
Review

Exosomes in Alzheimer's Disease: Potential Role as Pathological Mediators, Biomarkers and Therapeutic Targets

Sreeja Lakshmi et al. Neurochem Res. 2020 Nov.

Abstract

The concept of exosomes has been progressively changed from the status of cellular trashcans to multitasking organelles involved in many processes, including internalization, transport and transfer of macromolecules such as proteins, lipids and nucleic acids. While underpinning the mechanisms behind neurodegeneration and neuronal loss, exosomes were shown to be involved in carrying pathological misfolded proteins, propagation of β-amyloid protein and hyper-phosphorylated tau proteins across the brain that ultimately leads to the onset of Alzheimer's disease (AD), the most prevailing multifactorial neurodegenerative disorder. A potential novel therapeutic role of exosomes in AD intervention is suggested by their ability to increase Aβ clearance. This review aims to highlight the important pathological mechanisms as well as therapeutic strategies involving exosomes towards AD prevention.

Keywords: Alzheimer´s disease; Biomarkers; Exosomes; Tau protein; β-amyloid.

PubMed Disclaimer

References

    1. Prince M, Comas-Herrera A, Knapp M, Guerchet M, Karagiannidou M (2016) World Alzheimer report 2016- improving healthcare for people living with Dementia. Coverage, quality and costs now and in the future.
    1. Querfurth HW, LaFerla FM (2010) Alzheimer’s disease. N Engl J Med 362:329–344 - PubMed
    1. Hampel H, Prvulovic D, Teipel S, Jessen F, Luckhaus C et al (2011) The future of Alzheimer’s disease: the next 10 years. Prog Neurobiol 95:718–728 - PubMed
    1. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356 - PubMed
    1. Jiang L, Dong H, Cao H, Ji X, Luan S, Liu J (2019) Exosomes in pathogenesis, diagnosis, and treatment of Alzheimer’s Disease. Med Sci Monit 25:3329–3335 - PubMed - PMC

LinkOut - more resources